Drugs developer secures funding for skin treatment
Andrew Woodland: humbled
Research scientist Andrew Woodland from the University of Dundee has picked up a £74,500 package of support to develop his company’s drugs treatment for skin diseases.
Dr Woodland will launch In4Derm in March next year, after securing the cash and benefits prize in the Converge Challenge competition.
The 43-year-old from Paisley intends to spin out the company with five staff. He hopes the £50,000 cash element will be matched by Scottish Enterprise.
After being presented with his prize at a dinner held at the V&A Dundee, he said: “To emerge as winner from the final eight-strong field of exceptionally talented innovators is truly humbling and the most amazing confidence-building boost any academic entrepreneur could have.
“Plus the prize package will really help me to develop the business – not just from a financial perspective, but also the network that comes with it.”
The annual competition marks achievements in academic innovation and entrepreneurship for staff, students and recent graduates across all Scottish universities.
More than 200 guests including university principals, investors, entrepreneurs and those from the wider business eco-system celebrated a diverse range of projects across health care, the creative industries, renewables and food security.